Washington, DC’ Kit Check™ (https://kitcheck.com), the leader in hospital pharmacy kit processing and medication tracking software, today announced that the United States Patent and Trademark Office has issued the company two meaningful patents, with two additional patents set to issue on June 16, 2015. These awards represent a robust portfolio of intellectual property (IP) related to the Kit Check product.
The two patents granted to Kit Check are U.S. Patent Numbers 8,990,099 and 9,037,479. The two additional patents are expected to issue as U.S. Patent Numbers 9,058,412 and 9,058,413.
’Kit Check was founded on innovations for medication tracking and processing. Our engineering team invented hospital pharmacy kit restocking automation and has applied these unique technologies and approaches to other areas of hospital medication tracking. We are pleased the U.S. Patent and Trademark Office agreed our inventions are meaningful and merit patent protection,” said Kit Check co-founder and chief product officer Tim Kress-Spatz.
Kit Check’s management team believes these patents represent significant intellectual property protection while providing assurance to Kit Check customers that the innovative technology is unique and protected. The Kit Check team expects this growing patent portfolio to be further augmented as the company continues to innovate.
About Kit Check™
Kit Check™ is the leader in automated hospital pharmacy kit processing and medication tracking software. Since 2012, Kit Check™ has focused on replacing time consuming and error prone manual processes in hospital medication handling with faster and safer automation technologies driven by a scalable cloud software platform. Kit Check™ is headquartered in Washington, DC and serves hospitals throughout the United States. For more information please contact Kit Check™ by email at PR@kitcheck.com or call at (786) 548-2432 ext. 5.